CytomX Therapeutics
CTMX
CTMX
62 hedge funds and large institutions have $41.8M invested in CytomX Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
56% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 25
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
62
Holding in Top 10
–
Calls
$61K
Puts
$4K
Top Buyers
| 1 | +$303K | |
| 2 | +$173K | |
| 3 | +$66.2K | |
| 4 |
Millennium Management
New York
|
+$64K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$41.6K |
Top Sellers
| 1 | -$734K | |
| 2 | -$592K | |
| 3 | -$383K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$312K |
| 5 |
Renaissance Technologies
New York
|
-$248K |